Eventide Asset Management - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 66 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q4 2017$2,921,000
-7.9%
463,7000.0%0.15%
-15.6%
Q3 2017$3,172,000
-25.9%
463,700
-22.7%
0.18%
-32.3%
Q2 2017$4,278,000
-22.4%
600,0000.0%0.27%
-27.1%
Q1 2017$5,514,000
+128.0%
600,0000.0%0.36%
+132.5%
Q4 2016$2,418,000
+5.2%
600,0000.0%0.16%
+12.1%
Q3 2016$2,298,000
-10.9%
600,0000.0%0.14%
-11.4%
Q2 2016$2,580,000
+84.7%
600,000
+330.7%
0.16%
+125.7%
Q4 2015$1,397,000
+7.6%
139,300
-19.9%
0.07%
-6.7%
Q3 2015$1,298,000
-90.6%
174,000
-40.0%
0.08%
-89.9%
Q2 2015$13,758,000
+29.5%
290,0000.0%0.74%
-7.0%
Q1 2015$10,626,000
-7.7%
290,0000.0%0.80%
-36.4%
Q4 2014$11,516,000
+91.8%
290,000
-3.6%
1.26%
+50.0%
Q3 2014$6,003,000
+47.9%
300,9000.0%0.84%
+51.8%
Q2 2014$4,059,000
+23.9%
300,9000.0%0.55%
+8.4%
Q1 2014$3,277,000
+150.9%
300,900
+211.5%
0.51%
+26.6%
Q4 2013$1,306,00096,6000.40%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q1 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 317,900$11,647,0004.28%
Opaleye Management Inc. 175,000$6,412,0002.98%
Graticule Asia Macro Advisors LLC 413,200$15,139,0002.02%
BB BIOTECH AG 1,477,114$54,121,0001.61%
Iguana Healthcare Management, LLC 75,000$2,748,0001.16%
Granite Point Capital Management, L.P. 79,250$2,904,0001.06%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 458,202$16,788,0000.89%
Ghost Tree Capital, LLC 130,000$4,764,0000.86%
SECTORAL ASSET MANAGEMENT INC 605,393$22,182,0000.84%
HealthCor Management, L.P. 467,200$17,118,0000.82%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders